ChosenSecurity Cross-Certifies With SAFE-BioPharma Bridge Certificate Authority


Share on LinkedIn

Kate Lewis Elyse Familant
ChosenSecurity, Inc. George Cohen Communications
617-559-0090, x109 978-725-3637
[email protected] [email protected]

ChosenSecurity Cross-Certifies with SAFE-BioPharma? Bridge Certificate Authority

ChosenSecurity along with TransSped, selected by SAIC to offer EU Qualified Certificates as an Integrated Security Solution for the Biopharmaceutical Industry

NEWTON, MA – May 6, 2008 – ChosenSecurity, Inc., the leading provider of On-Demand Public Key Infrastructure (PKI) security services, today announced that it has cross-certified with the SAFE-BioPharma Bridge Certificate Authority and will offer digital certificates for the pharmaceutical and healthcare industries. The SAFE-BioPharma digital identity and signature standard provides a secure, enforceable, and regulatory-compliant way to sign business-to-business and business-to-regulator electronic transactions within the biopharmaceutical and healthcare industries. ChosenSecurity and its partner TransSped srl have been selected by Science Applications International Corporation (SAIC) [NYSE: SAIC], a scientific, engineering, and technology applications company that provides identity and access management solutions, to provide a Certification Authority service that is integrated into SAIC’s solution for industry.

Cross-certification with the SAFE-BioPharma Bridge enables ChosenSecurity to offer digital certificates to the growing pharmaceutical community. It is essential to have certificates for processes, such as signing lab tests, lab results or medical papers, to enable them to stand up in a court of law. As an international company, ChosenSecurity’s high standards in issuing digital certificates meet the strict requirements of the European Union (EU).

“The biopharmaceutical industry established SAFE-BioPharma as an interoperable digital identity and signature standard. SAFE-BioPharma is now being used in a variety of business functions and technology environments,” said Dean Coclin, ChosenSecurity’s Vice President of Business Development. “ChosenSecurity, with its expertise, is squarely positioned to successfully support SAFE-BioPharma implementations and extend security solutions to the biopharmaceutical industry.”

In addition to offering certificates directly to the biopharmaceutical industry, ChosenSecurity will be offering certificates with SAIC, as part of an integrated security solution. SAIC selected ChosenSecurity based on the company’s years of experience and presence in Europe and having already met the EU standards and approval of strong authentication and hardware requirements.

“We are delighted to work with ChosenSecurity and offer an integrated service offering,” said Guy Tallent, Vice President of Identity and Access Management, SAIC.

The SAFE-BioPharma digital standard was established by the biopharmaceutical industry to help it transform to a fully electronic environment from inefficient paper-based business and regulatory processes. SAFE-BioPharma provides a high level of trust assurance for digital identities, which are uniquely bound to corresponding digital signatures.

“By cross-certifying with the SAFE-BioPharma Bridge, ChosenSecurity will be able to offer certificates to our member companies that can be used in support of global business and regulatory transactions,” said Mollie Shields-Uehling, President and CEO, SAFE-BioPharma. “We are pleased they were selected by SAIC to participate in offering this important integrated solution to the biopharmaceutical industry.”

About SAFE-BioPharma Association
SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries. The SAFE-BioPharma standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. SAFE-BioPharma’s vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012. The Association’s members include Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. For more information, visit

About ChosenSecurity, Inc.
ChosenSecurity is the leading provider of On-Demand PKI (public key infrastructure) security services in the world, enabling a wide range of PKI-enabled security services for enterprise authentication, secure e-mail and digital signatures. The Company delivers breakthrough economics and implementation speed to the Enterprise; up to 70% less than in-house implementations, 50% less than traditional managed services, and can be implemented in just a few weeks.

Unlike traditional PKI implementations, ChosenSecurity is the world’s first PKI that can be deployed across multiple clients in a web-based Security as a Service model, enabling any sized enterprise to achieve PKI security in a few weeks with no capital costs, hardware, software or network changes. Headquartered in Newton, MA, ChosenSecurity is a true leader of certification service providers at the forefront of identity management. For additional information, please visit

# # #
All product names are trademarks or registered trademarks of their respective owners.

News Editor
CustomerThink offers a free news posting service for press releases relevant to our community. To submit your press release to our news editor, send an email to [email protected] with the press release headline and main content in the email subject line and body, respectively. That's it! Approved press releases will appear in our news category within one business day of submission.


Please use comments to add value to the discussion. Maximum one link to an educational blog post or article. We will NOT PUBLISH brief comments like "good post," comments that mainly promote links, or comments with links to companies, products, or services.

Please enter your comment!
Please enter your name here